Bliss GVS Pharma Ltd
Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products.
- Market Cap ₹ 1,037 Cr.
- Current Price ₹ 101
- High / Low ₹ 224 / 85.0
- Stock P/E 13.2
- Book Value ₹ 74.5
- Dividend Yield 0.50 %
- ROCE 18.3 %
- ROE 15.4 %
- Face Value ₹ 1.00
Pros
- No pros found. Suggest something.
Cons
- The company has delivered a poor sales growth of 11.11% over past five years.
- Promoter holding is low: 33.31%
- Dividend payout has been low at 10.39% of profits over last 3 years
- Company has high debtors of 290.13 days.
- Promoter holding has decreased over last 3 years: -26.85%
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
219 | 267 | 397 | 345 | 407 | 547 | 798 | 815 | 899 | 689 | 565 | |
160 | 196 | 285 | 273 | 304 | 391 | 596 | 621 | 739 | 567 | 459 | |
Operating Profit | 59 | 71 | 111 | 71 | 103 | 156 | 203 | 193 | 160 | 122 | 106 |
OPM % | 27% | 27% | 28% | 21% | 25% | 29% | 25% | 24% | 18% | 18% | 19% |
Other Income | 2 | 16 | 14 | 28 | 20 | 24 | 12 | -4 | 35 | 25 | 17 |
Interest | 2 | 4 | 10 | 18 | 16 | 19 | 20 | 23 | 4 | 5 | 6 |
Depreciation | 5 | 4 | 6 | 11 | 11 | 13 | 20 | 21 | 9 | 13 | 16 |
Profit before tax | 53 | 79 | 109 | 71 | 96 | 148 | 175 | 145 | 182 | 129 | 101 |
Tax % | 23% | 34% | 46% | 42% | 36% | 32% | 36% | 39% | 30% | 26% | |
Net Profit | 41 | 53 | 58 | 41 | 60 | 82 | 82 | 59 | 124 | 97 | 71 |
EPS in Rs | 3.94 | 5.09 | 5.60 | 3.97 | 5.81 | 8.00 | 7.95 | 5.70 | 11.99 | 9.43 | 6.89 |
Dividend Payout % | 15% | 15% | 12% | 13% | 12% | 6% | 8% | 18% | 8% | 5% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | -5% |
TTM: | -31% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 9% |
TTM: | -26% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | -4% |
3 Years: | -21% |
1 Year: | 0% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 17% |
Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Reserves | 156 | 200 | 248 | 277 | 327 | 402 | 476 | 526 | 636 | 725 | 758 |
Borrowings | 8 | 45 | 148 | 173 | 160 | 132 | 225 | 118 | 102 | 126 | 129 |
39 | 54 | 165 | 123 | 166 | 218 | 311 | 206 | 157 | 170 | 183 | |
Total Liabilities | 213 | 310 | 571 | 583 | 662 | 762 | 1,023 | 860 | 905 | 1,032 | 1,080 |
20 | 40 | 168 | 213 | 234 | 225 | 305 | 143 | 146 | 242 | 239 | |
CWIP | 8 | 7 | 1 | 4 | 0 | 9 | 4 | 0 | 47 | 0 | 0 |
Investments | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
186 | 262 | 402 | 365 | 428 | 527 | 714 | 717 | 712 | 790 | 841 | |
Total Assets | 213 | 310 | 571 | 583 | 662 | 762 | 1,023 | 860 | 905 | 1,032 | 1,080 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
36 | 6 | 41 | 38 | 113 | 289 | 18 | 40 | 45 | ||
-22 | -124 | -11 | -29 | -50 | -249 | 48 | -79 | -41 | ||
26 | 110 | -8 | -42 | -40 | -10 | -76 | 17 | -4 | ||
Net Cash Flow | 40 | -8 | 22 | -34 | 23 | 30 | -10 | -22 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 39% | 36% | 20% | 24% | 32% | 31% | 29% | 27% | 18% | |
Debtor Days | 200 | 176 | 225 | 228 | 222 | 201 | 116 | 134 | 187 | 290 |
Inventory Turnover | 13.05 | 9.09 | 5.34 | 5.49 | 7.27 | 8.29 | 7.32 | 9.05 | 5.78 |
Documents
Recent announcements
- Shareholding for the Period Ended March 31, 2021 2d
- Statement Of Investor Complaints For The Quarter Ended March 2021 2d
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 14 Apr
- Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Options Plan 2019 6 Apr
- Clarification On Price Movement 1 Apr
View all